Movers: Albireo, CinCor, Duck Creek, Goldman Sachs, Lulu Lemon, Teladoc
- Scott Peters
- U.S.A. New York City
-
Biotech firms Albireo agreed to be acquired by France-based Ipsen and CinCor by AstraZaneca. Duck Creek Tech agreed to go private. Lululemon's guidance disappointed investors. Teladoc narrowed its fourth quarter revenue outlook.
Tech stock rally powered broader market rally for the second day in a row on the hopes that the Federal Reserve Bank may slow future rate hikes in its campaign against inflation.
Albireo Pharma Inc soared 92% to $43.82 after the US-based rare liver disease focused company agreed to merge with the French biopharma company Ipsen.
Ipsen SA increased 0.5% to
Annual Returns
| Company | Ticker | 2025 | 2024 | 2023 |
|---|---|---|---|---|
| Albireo Pharma Inc | ALBO | 0% | 0% | 108% |
| Duck Creek Technologies Inc. | DCT | 0% | 0% | 62% |
| lululemon athletica inc | LULU | -3% | -25% | 57% |
| Tesla Inc | TSLA | -12% | 74% | 48% |
| CinCor Pharma Inc. | CINC | 0% | 0% | 137% |
| Goldman Sachs Group Inc The | GS | 1% | 48% | 6% |
| Teladoc Health Inc. | TDOC | 4% | -58% | -23% |